Laman UtamaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹482.45
Julat hari
₹488.50 - ₹526.40
Julat tahun
₹480.00 - ₹899.00
Permodalan pasaran
25.84B INR
Bilangan Purata
105.52K
Nisbah P/E
137.61
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 2.07B | -4.64% |
Perbelanjaan pengendalian | 715.86J | -4.29% |
Pendapatan bersih | -126.14J | -160.71% |
Margin untung bersih | -6.09 | -163.70% |
Pendapatan bagi setiap syer | -1.08 | — |
EBITDA | 10.45J | -95.93% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.49B | -39.11% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 12.74B | — |
Syer tertunggak | 50.66J | — |
Harga kepada buku | 1.92 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | -1.20% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -126.14J | -160.71% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Diasaskan
1992
Tapak web
Pekerja
736
